The FDA today approved a new 200 unit/mL formulation of Lilly’s Humalog KwikPen for patients with type 1 and type 2 diabetes.
Noting national drug shortages often disproportionately affect pediatric patients, the Pediatric Pharmacy Advocacy Group (PPAG) is encouraging the FDA to include child-specific considerations in its policies for preventing and mitigating drug shortages.
Hospitals serving large populations of non-native English speakers perform worse on patient satisfaction scores that are tied to reimbursement from the US Centers for Medicare and Medicaid Services.
The FDA today approved a new treatment for chronic obstructive pulmonary disease: tiotropium bromide and olodaterol inhalation spray.
The FDA had accepted for review Tris Pharma’s New Drug Application for its extended-release liquid amphetamine to treat ADHD in children.